Study how phosphate handling affects healthy aging
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This early study looks at how the body’s handling of phosphate may affect aging and bone health. It is meant for people with certain rare genetic conditions that change phosphate levels, to better understand their biology and responses to study tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 13 years old
- You need a confirmed genetic diagnosis (XLH or HHRH) with specific gene changes
- You must be willing to share past medical records (tests, scans, and treatment/surgery history)
- You must be able and willing to attend scheduled study visits and complete study assessments
- You should not have other major illnesses that affect phosphate or bone health (like kidney, liver, gut problems, or cancer)
- If Aim 2 applies, you must be able to tolerate extra phosphate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with hypoparathyroidism to better understand what symptoms and lab levels change over time. It may help doctors plan future treatments by learning the natural course of the condition, even if you already take standard medicines.
This study measures how your body handles extra phosphate in the diet and whether this changes with your age and gender. It may help doctors understand more about bone and kidney health.
This study uses a special MRI scan to look at phosphorus levels in the muscles of people with phosphate diabetes (a condition where the body loses too much phosphate through the kidneys). It aims to better understand how this condition affects muscles and may help guide future treatments.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
This study follows people who already have hypophosphatasia (HPP) to better understand how the condition changes over time. It may help doctors recognize patterns and improve care, even if you are not receiving a new treatment.
This is a long-term observational study (not a drug trial) that follows adults with signs of hypophosphatasia, a condition linked to very low alkaline phosphatase levels and sometimes a gene change. It aims to better understand the condition over time and how symptoms look and progress.
Hear when a new Hypophosphatemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.